CA2674632A1 - Dual-functional nonfouling surfaces and materials - Google Patents
Dual-functional nonfouling surfaces and materials Download PDFInfo
- Publication number
- CA2674632A1 CA2674632A1 CA002674632A CA2674632A CA2674632A1 CA 2674632 A1 CA2674632 A1 CA 2674632A1 CA 002674632 A CA002674632 A CA 002674632A CA 2674632 A CA2674632 A CA 2674632A CA 2674632 A1 CA2674632 A1 CA 2674632A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- target binding
- polymers
- carboxybetaine
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title abstract description 38
- 230000027455 binding Effects 0.000 claims abstract description 92
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 73
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 50
- 229920000642 polymer Polymers 0.000 claims description 127
- -1 antibodies Proteins 0.000 claims description 51
- 239000000758 substrate Substances 0.000 claims description 50
- 125000002843 carboxylic acid group Chemical group 0.000 claims description 49
- 229920006037 cross link polymer Polymers 0.000 claims description 38
- 239000000178 monomer Substances 0.000 claims description 37
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 29
- 239000000017 hydrogel Substances 0.000 claims description 27
- 230000008878 coupling Effects 0.000 claims description 20
- 238000010168 coupling process Methods 0.000 claims description 20
- 238000005859 coupling reaction Methods 0.000 claims description 20
- 125000002947 alkylene group Chemical group 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 17
- 230000007935 neutral effect Effects 0.000 claims description 17
- 229920001400 block copolymer Polymers 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 125000003277 amino group Chemical group 0.000 claims description 14
- 239000002356 single layer Substances 0.000 claims description 14
- 239000000427 antigen Substances 0.000 claims description 13
- 108091007433 antigens Proteins 0.000 claims description 13
- 102000036639 antigens Human genes 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000003446 ligand Substances 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 230000002209 hydrophobic effect Effects 0.000 claims description 10
- 108020003175 receptors Proteins 0.000 claims description 10
- 102000005962 receptors Human genes 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 150000003926 acrylamides Chemical class 0.000 claims description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002105 nanoparticle Substances 0.000 claims description 5
- 150000001408 amides Chemical class 0.000 claims description 4
- 239000011859 microparticle Substances 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 229920000570 polyether Chemical group 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004721 Polyphenylene oxide Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 150000002118 epoxides Chemical class 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 abstract description 36
- 230000021164 cell adhesion Effects 0.000 abstract description 12
- 239000012620 biological material Substances 0.000 abstract description 7
- 230000004071 biological effect Effects 0.000 abstract description 4
- 238000012377 drug delivery Methods 0.000 abstract description 3
- 238000010364 biochemical engineering Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 69
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 50
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 42
- 239000000243 solution Substances 0.000 description 29
- CYUZOYPRAQASLN-UHFFFAOYSA-N 3-prop-2-enoyloxypropanoic acid Chemical compound OC(=O)CCOC(=O)C=C CYUZOYPRAQASLN-UHFFFAOYSA-N 0.000 description 28
- 102000008946 Fibrinogen Human genes 0.000 description 26
- 108010049003 Fibrinogen Proteins 0.000 description 26
- 229940012952 fibrinogen Drugs 0.000 description 26
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 25
- 239000002953 phosphate buffered saline Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000006116 polymerization reaction Methods 0.000 description 17
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 16
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 16
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 16
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 229920001577 copolymer Polymers 0.000 description 14
- IZMVGEWQSBMVIU-UHFFFAOYSA-N 2-(2-azaniumyl-1-hydroxycyclobutyl)acetate Chemical compound NC1CCC1(O)CC(O)=O IZMVGEWQSBMVIU-UHFFFAOYSA-N 0.000 description 12
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- 210000002381 plasma Anatomy 0.000 description 12
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 10
- 239000010931 gold Substances 0.000 description 10
- 229910052737 gold Inorganic materials 0.000 description 10
- 239000003999 initiator Substances 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 102000016359 Fibronectins Human genes 0.000 description 9
- 108010067306 Fibronectins Proteins 0.000 description 9
- 230000004913 activation Effects 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 8
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 229920000359 diblock copolymer Polymers 0.000 description 8
- 125000000524 functional group Chemical group 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 238000003498 protein array Methods 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 7
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- 102000016943 Muramidase Human genes 0.000 description 7
- 108010014251 Muramidase Proteins 0.000 description 7
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 7
- 241000607142 Salmonella Species 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 229960000274 lysozyme Drugs 0.000 description 7
- 239000004325 lysozyme Substances 0.000 description 7
- 235000010335 lysozyme Nutrition 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 238000011065 in-situ storage Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000001338 self-assembly Methods 0.000 description 6
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 5
- YHHSONZFOIEMCP-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethyl hydrogen phosphate Chemical compound C[N+](C)(C)CCOP(O)([O-])=O YHHSONZFOIEMCP-UHFFFAOYSA-N 0.000 description 5
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 5
- YOCIJWAHRAJQFT-UHFFFAOYSA-N 2-bromo-2-methylpropanoyl bromide Chemical compound CC(C)(Br)C(Br)=O YOCIJWAHRAJQFT-UHFFFAOYSA-N 0.000 description 5
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 5
- WIYVVIUBKNTNKG-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)=CC2=C1C=C(OC)C(OC)=C2 WIYVVIUBKNTNKG-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 239000013580 millipore water Substances 0.000 description 5
- 150000002924 oxiranes Chemical class 0.000 description 5
- 229950004354 phosphorylcholine Drugs 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 229960000380 propiolactone Drugs 0.000 description 5
- 238000002731 protein assay Methods 0.000 description 5
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- ULGGZAVAARQJCS-UHFFFAOYSA-N 11-sulfanylundecan-1-ol Chemical compound OCCCCCCCCCCCS ULGGZAVAARQJCS-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 210000002403 aortic endothelial cell Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000007942 carboxylates Chemical group 0.000 description 4
- 238000000572 ellipsometry Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000009871 nonspecific binding Effects 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- 238000010526 radical polymerization reaction Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 230000009870 specific binding Effects 0.000 description 4
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 3
- XSHISXQEKIKSGC-UHFFFAOYSA-N 2-aminoethyl 2-methylprop-2-enoate;hydron;chloride Chemical compound Cl.CC(=C)C(=O)OCCN XSHISXQEKIKSGC-UHFFFAOYSA-N 0.000 description 3
- CSWRCKVZMMKVDC-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propanoate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCC([O-])=O CSWRCKVZMMKVDC-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- 108091006629 SLC13A2 Proteins 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- 239000008204 material by function Substances 0.000 description 3
- 102000006240 membrane receptors Human genes 0.000 description 3
- 108020004084 membrane receptors Proteins 0.000 description 3
- 238000000813 microcontact printing Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000012146 running buffer Substances 0.000 description 3
- 239000007974 sodium acetate buffer Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLJQPXVBQNJNLW-UHFFFAOYSA-N 1-methylaziridine Chemical compound CN1CC1 XLJQPXVBQNJNLW-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000012480 LAL reagent Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003575 carbonaceous material Substances 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 229940096384 chicken egg white lysozyme Drugs 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000005566 electron beam evaporation Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229920001600 hydrophobic polymer Polymers 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 150000002482 oligosaccharides Polymers 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 description 1
- OMEBWCFMNYDCFP-UHFFFAOYSA-N 1-sulfanylundecan-1-ol Chemical compound CCCCCCCCCCC(O)S OMEBWCFMNYDCFP-UHFFFAOYSA-N 0.000 description 1
- JVQTWZGZUCJHRV-UHFFFAOYSA-N 11-sulfanylundecyl 2-bromo-2-methylpropanoate Chemical compound CC(C)(Br)C(=O)OCCCCCCCCCCCS JVQTWZGZUCJHRV-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010024212 E-Selectin Proteins 0.000 description 1
- 102100023471 E-selectin Human genes 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010035766 P-Selectin Proteins 0.000 description 1
- 102100023472 P-selectin Human genes 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 101100073357 Streptomyces halstedii sch2 gene Proteins 0.000 description 1
- QTENRWWVYAAPBI-YZTFXSNBSA-N Streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@H]1[C@H](N=C(N)N)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]1O QTENRWWVYAAPBI-YZTFXSNBSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 150000001224 Uranium Chemical class 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical class C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000012578 cell culture reagent Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- WGFQMVAMYUNYLF-UHFFFAOYSA-N ethyl 2-hydroxyacetate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)CO WGFQMVAMYUNYLF-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 238000003368 label free method Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- KUHRIIPUCPOQMQ-UHFFFAOYSA-N n,n-diethyl-3-(ethyliminomethylideneamino)propan-1-amine Chemical compound CCN=C=NCCCN(CC)CC KUHRIIPUCPOQMQ-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002946 poly[2-(methacryloxy)ethyl phosphorylcholine] polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- PNOXUQIZPBURMT-UHFFFAOYSA-M potassium;3-(2-methylprop-2-enoyloxy)propane-1-sulfonate Chemical compound [K+].CC(=C)C(=O)OCCCS([O-])(=O)=O PNOXUQIZPBURMT-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001105 surface plasmon resonance spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- DNYWZCXLKNTFFI-UHFFFAOYSA-N uranium Chemical compound [U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U] DNYWZCXLKNTFFI-UHFFFAOYSA-N 0.000 description 1
- 125000005500 uronium group Chemical group 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F122/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
- C08F122/10—Esters
- C08F122/12—Esters of phenols or saturated alcohols
- C08F122/22—Esters containing nitrogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88282106P | 2006-12-29 | 2006-12-29 | |
| US60/882,821 | 2006-12-29 | ||
| PCT/US2007/089236 WO2008083390A2 (en) | 2006-12-29 | 2007-12-31 | Dual-functional nonfouling surfaces and materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2674632A1 true CA2674632A1 (en) | 2008-07-10 |
Family
ID=39589238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002674632A Abandoned CA2674632A1 (en) | 2006-12-29 | 2007-12-31 | Dual-functional nonfouling surfaces and materials |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US8835144B2 (https=) |
| EP (1) | EP2104846A2 (https=) |
| JP (1) | JP2010530955A (https=) |
| CA (1) | CA2674632A1 (https=) |
| MX (1) | MX2009007101A (https=) |
| WO (1) | WO2008083390A2 (https=) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5560393B2 (ja) * | 2005-06-22 | 2014-07-23 | アステリアス バイオセラピューティクス インコーポレイテッド | 心筋細胞系列細胞への霊長類多能性幹細胞の分化 |
| US20110097277A1 (en) | 2005-08-25 | 2011-04-28 | University Of Washington | Particles coated with zwitterionic polymers |
| MX2009007101A (es) | 2006-12-29 | 2009-12-01 | Univ Washington | Superficies y materiales antibioincrustación bifuncionales. |
| US8753304B2 (en) | 2007-08-17 | 2014-06-17 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters having acoustically actuatable waveguide components for delivering a sterilizing stimulus to a region proximate a surface of the catheter |
| US8702640B2 (en) | 2007-08-17 | 2014-04-22 | The Invention Science Fund I, Llc | System, devices, and methods including catheters configured to monitor and inhibit biofilm formation |
| US8734718B2 (en) | 2007-08-17 | 2014-05-27 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component |
| US8647292B2 (en) | 2007-08-17 | 2014-02-11 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters having components that are actively controllable between two or more wettability states |
| US8706211B2 (en) | 2007-08-17 | 2014-04-22 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters having self-cleaning surfaces |
| US8162924B2 (en) | 2007-08-17 | 2012-04-24 | The Invention Science Fund I, Llc | System, devices, and methods including actively-controllable superoxide water generating systems |
| US8114346B2 (en) | 2007-08-17 | 2012-02-14 | The Invention Science Fund I, Llc | Event-triggered ultraviolet light sterilization of surfaces |
| US8460229B2 (en) | 2007-08-17 | 2013-06-11 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters having components that are actively controllable between transmissive and reflective states |
| US8029740B2 (en) | 2008-07-11 | 2011-10-04 | The Invention Science Fund I, Llc | Event-triggered self-sterilization of article surfaces |
| US8366652B2 (en) | 2007-08-17 | 2013-02-05 | The Invention Science Fund I, Llc | Systems, devices, and methods including infection-fighting and monitoring shunts |
| US7943370B2 (en) * | 2007-08-23 | 2011-05-17 | Canon Kabushiki Kaisha | Structure, target substance detection element and target substance detection kit |
| US9533006B2 (en) | 2007-11-19 | 2017-01-03 | University Of Washington | Marine coatings |
| US20090149673A1 (en) * | 2007-12-05 | 2009-06-11 | Semprus Biosciences Corp. | Synthetic non-fouling amino acids |
| SG188096A1 (en) | 2008-01-30 | 2013-03-28 | Geron Corp | Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
| EP2247718B1 (en) | 2008-01-30 | 2019-01-16 | Asterias Biotherapeutics, Inc. | Synthetic surfaces for culturing stem cell derived cardiomyocytes |
| US8329469B2 (en) * | 2008-01-30 | 2012-12-11 | Geron Corporation | Swellable (meth)acrylate surfaces for culturing cells in chemically defined media |
| US8354274B2 (en) * | 2008-01-30 | 2013-01-15 | Geron Corporation | Synthetic surfaces for culturing cells in chemically defined media |
| US9474831B2 (en) | 2008-12-04 | 2016-10-25 | Gearbox, Llc | Systems, devices, and methods including implantable devices with anti-microbial properties |
| WO2010065135A1 (en) | 2008-12-04 | 2010-06-10 | Searete, Llc | System, devices, and methods including actively-controllable sterilizing excitation delivery implants |
| US8585627B2 (en) | 2008-12-04 | 2013-11-19 | The Invention Science Fund I, Llc | Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure |
| WO2010065960A2 (en) * | 2008-12-05 | 2010-06-10 | Semprus Biosciences Corp. | Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions |
| EP2352796A1 (en) | 2008-12-05 | 2011-08-10 | Semprus Biociences Corporation | Layered non-fouling, antimicrobial, antithrombogenic coatings |
| EP2393381B1 (en) | 2009-02-03 | 2018-10-31 | Agtec Innovations, Inc. | Micronutrient fertilizers and methods of making and using the same |
| US9181137B2 (en) | 2009-03-20 | 2015-11-10 | Agtec Innovations, Inc. | Micronutrient fertilizers and methods of making and using the same |
| TW201042038A (en) | 2009-05-28 | 2010-12-01 | Corning Inc | Synthetic microcarriers for culturing cells |
| EP2480892A1 (en) | 2009-09-25 | 2012-08-01 | Origene Technologies, Inc. | Protein arrays and uses thereof |
| JP5868862B2 (ja) | 2009-11-06 | 2016-02-24 | ユニヴァーシティ・オブ・ワシントン・スルー・イッツ・センター・フォー・コマーシャリゼーション | 双性イオンポリマーバイオコンジュゲートおよび関連する方法 |
| WO2011057219A2 (en) | 2009-11-06 | 2011-05-12 | University Of Washington Through Its Center For Commercialization | Crosslinked zwitterionic hydrogels |
| CA2799786A1 (en) | 2010-06-09 | 2011-12-15 | Semprus Biosciences Corp. | Non-fouling, anti-microbial, anti-thrombogenic graft compositions |
| AU2011264834B2 (en) * | 2010-06-09 | 2015-03-12 | Semprus Biosciences Corp. | Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions |
| WO2011156596A2 (en) | 2010-06-09 | 2011-12-15 | Semprus Biosciences Corp. | Articles having non-fouling surfaces and processes for preparing the same including pretreatment of substrates |
| AU2011288133B2 (en) | 2010-08-10 | 2014-02-27 | Agtec Innovations, Inc. | Polyphosphate fertilizer combinations |
| CA2806475C (en) | 2010-08-10 | 2016-11-29 | Chandrika Varadachari | Phosphate fertilizers and methods of using the same |
| US9511151B2 (en) | 2010-11-12 | 2016-12-06 | Uti Limited Partnership | Compositions and methods for the prevention and treatment of cancer |
| JP5866880B2 (ja) * | 2011-02-10 | 2016-02-24 | 住友ベークライト株式会社 | 生理活性物質固定化用粒子、生理活性物質固定粒子及び糖親和性物質捕捉粒子 |
| EP2726870B1 (en) | 2011-06-29 | 2018-10-03 | Academia Sinica | The capture, purification and release of biological substance using a surface coating |
| CA2872378C (en) | 2011-07-20 | 2016-01-12 | University Of Washington Through Its Center For Commercialization | Photonic blood typing |
| US9101678B2 (en) | 2011-11-03 | 2015-08-11 | Elwha Llc | Heat-sanitization of surfaces |
| CA2858730C (en) | 2011-12-14 | 2017-07-18 | Semprus Biosciences Corp. | Surface modified contact lenses |
| CA2859195C (en) | 2011-12-14 | 2016-09-27 | Semprus Biosciences Corp. | Imbibing process for contact lens surface modification |
| WO2013090790A1 (en) | 2011-12-14 | 2013-06-20 | Semprus Biosciences Corp. | Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants |
| US9000063B2 (en) | 2011-12-14 | 2015-04-07 | Semprus Biosciences Corporation | Multistep UV process to create surface modified contact lenses |
| US9120119B2 (en) | 2011-12-14 | 2015-09-01 | Semprus Biosciences Corporation | Redox processes for contact lens modification |
| US10031138B2 (en) | 2012-01-20 | 2018-07-24 | University Of Washington Through Its Center For Commercialization | Hierarchical films having ultra low fouling and high recognition element loading properties |
| US10988516B2 (en) | 2012-03-26 | 2021-04-27 | Uti Limited Partnership | Methods and compositions for treating inflammation |
| US9603948B2 (en) | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
| TWI512103B (zh) | 2012-11-12 | 2015-12-11 | Ind Tech Res Inst | 細胞培養系統、以及無血清細胞培養方法 |
| AU2014343379B2 (en) | 2013-11-04 | 2019-02-14 | Uti Limited Partnership | Methods and compositions for sustained immunotherapy |
| TW201623605A (zh) | 2014-04-01 | 2016-07-01 | 中央研究院 | 用於癌症診斷及預後之方法及系統 |
| US10112198B2 (en) | 2014-08-26 | 2018-10-30 | Academia Sinica | Collector architecture layout design |
| JP6453590B2 (ja) * | 2014-09-08 | 2019-01-16 | Jsr株式会社 | 固相担体、リガンド結合固相担体、標的物質の検出又は分離方法、及び前記固相担体の製造方法 |
| JP6532202B2 (ja) * | 2014-09-08 | 2019-06-19 | Jsr株式会社 | 磁性粒子、リガンド結合粒子、標的物質の検出又は分離方法、及び前記磁性粒子の製造方法 |
| WO2016040489A1 (en) * | 2014-09-09 | 2016-03-17 | Shaoyi Jiang | Functionalized zwitterionic and mixed charge polymers, related hydrogels, and methds for their use |
| EP3291832B1 (en) | 2015-05-06 | 2025-09-03 | UTI Limited Partnership | Nanoparticle compositions for sustained therapy |
| CZ2015313A3 (cs) | 2015-05-07 | 2016-07-07 | Ústav makromolekulární chemie AV ČR, v. v. i. | Polymerní kartáče odolné proti depozici složek biologických médií, způsob jejich přípravy a jejich použití |
| US10107726B2 (en) | 2016-03-16 | 2018-10-23 | Cellmax, Ltd. | Collection of suspended cells using a transferable membrane |
| CA3027200A1 (en) | 2016-06-13 | 2017-12-21 | Massachusetts Institute Of Technology | Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis |
| CZ307026B6 (cs) | 2016-06-17 | 2017-11-22 | Ústav Fotoniky A Elektroniky Av Čr, V. V. I. | Způsob přípravy povrchu substrátu obsahujícího karboxybetainové funkční skupiny |
| US20200231838A1 (en) * | 2017-02-06 | 2020-07-23 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Foo | Self assembling mixed block copolymer for nanostructured functional films |
| CA3083748A1 (en) | 2017-11-29 | 2019-06-06 | Uti Limited Partnership | Methods of treating autoimmune disease |
| WO2019199499A1 (en) * | 2018-04-13 | 2019-10-17 | University Of Washington | Methods and apparatus for single biological nanoparticle analysis |
| US20210237002A1 (en) * | 2018-06-05 | 2021-08-05 | Rensselaer Polytechnic Institute | Rapid and facile membrane adsorber fabrication with ultra high binding capacity |
| US12559867B2 (en) | 2019-04-30 | 2026-02-24 | Cornell University | Fibers of polymers that have a backbone including a positively charged component of a zwitterionic moiety, and their use in implantable therapeutic delivery systems |
| US11752489B2 (en) * | 2019-10-16 | 2023-09-12 | Biohybrid Solutions Llc | Affinity dissolution of biomolecules for protein purification |
| US20220390443A1 (en) * | 2019-11-11 | 2022-12-08 | Oxford University Innovation Limited | Method of isolating a selected population of exosomes |
| JP7443396B2 (ja) * | 2019-11-28 | 2024-03-05 | 京セラ株式会社 | 共重合体、測定装置および測定用担体 |
| CN115244094B (zh) * | 2020-03-02 | 2024-03-19 | 京瓷株式会社 | 共聚物及其制造方法、测定装置以及测定用载体 |
| CZ309314B6 (cs) | 2020-05-14 | 2022-08-17 | Fyzikální Ústav Av Čr, V. V. I. | Polymerní kartáč obsahující terpolymer pro použití proti nespecifické adsorpci látek z biologických médií |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3671502A (en) | 1970-11-12 | 1972-06-20 | Kendall & Co | Betaine copolymers with hydroxyalkylacrylates and hydroxyalkylmethacrylates |
| US4138446A (en) | 1974-12-19 | 1979-02-06 | Sumitomo Chemical Company, Limited | Water-soluble high polymers and their preparation |
| GB1510689A (en) | 1974-12-19 | 1978-05-10 | Sumitomo Chemical Co | Preparation of water-soluble cationic high polymer |
| JPS5339909A (en) | 1976-09-24 | 1978-04-12 | Kawasaki Steel Co | Molten metal refining process |
| US4415388A (en) | 1981-06-22 | 1983-11-15 | Johnson & Johnson | Method of making absorbent bearing products |
| US4493926A (en) | 1984-01-04 | 1985-01-15 | General Electric Company | Dissociating ionically cross-linked siloxane polymers |
| US5204060A (en) | 1986-01-07 | 1993-04-20 | Berol Kemi Ab | Method for disinfection |
| DE3622993A1 (de) | 1986-07-09 | 1988-01-21 | Behringwerke Ag | Dispersionspolymere, biologisch aktive dispersionspolymere, verfahren zu ihrer herstellung und verwendung als diagnostisches mittel |
| JPS63234007A (ja) | 1987-03-23 | 1988-09-29 | Kohjin Co Ltd | 水溶性が良好なカチオン性重合体 |
| US4985023A (en) | 1988-05-09 | 1991-01-15 | Dow Corning Corporation | Antimicrobial superabsorbent articles |
| US4931328A (en) | 1988-08-19 | 1990-06-05 | Hewlett-Packard Company | Capillary tube with reduced protein interactions and controllable electroosmotic flow |
| DE69124903T2 (de) | 1990-10-01 | 1997-06-19 | Phillips Petroleum Co | Absorbierendes Polymer |
| SU1780673A1 (ru) | 1991-04-19 | 1992-12-15 | Tashk Farmatsevticheskij I | Фуhгицидhoe cpeдctbo |
| US5624711A (en) * | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| US5714360A (en) | 1995-11-03 | 1998-02-03 | Bsi Corporation | Photoactivatable water soluble cross-linking agents containing an onium group |
| US5925552A (en) * | 1996-04-25 | 1999-07-20 | Medtronic, Inc. | Method for attachment of biomolecules to medical devices surfaces |
| EP0856539A1 (en) | 1997-01-30 | 1998-08-05 | Mitsui Chemicals, Inc. | Cross-linked polymer |
| US7056532B1 (en) | 1997-06-13 | 2006-06-06 | Univ. Nebraska Bd. of Regents | Compositions for delivery of biological agents and methods for the preparation thereof |
| US7547445B2 (en) | 1998-03-19 | 2009-06-16 | Surmodics, Inc. | Crosslinkable macromers |
| US6361768B1 (en) | 1998-12-29 | 2002-03-26 | Pmd Holdings Corp. | Hydrophilic ampholytic polymer |
| DE60041255D1 (de) * | 1999-04-28 | 2009-02-12 | Eidgenoess Tech Hochschule | Polyionische beschichtungen für analytische und sensor-vorrichtungen |
| WO2000071591A1 (en) | 1999-05-26 | 2000-11-30 | Rhodia Inc. | Block polymers, compositions and methods of use for foams, laundry detergents, shower rinses and coagulants |
| EP1189553B1 (en) | 1999-06-24 | 2004-03-31 | Abbott Vascular Devices Limited | Balloon expandable stent |
| JP3853549B2 (ja) | 1999-11-10 | 2006-12-06 | 花王株式会社 | 機能性アルコール放出物質 |
| AU2001292092A1 (en) | 2000-10-06 | 2002-04-15 | Biocompatibles Uk Limited | Zwitterionic polymers |
| DE10132173A1 (de) | 2001-07-03 | 2003-01-23 | Goldschmidt Ag Th | Neue Betainester |
| EP1480619B1 (en) * | 2002-03-07 | 2013-08-07 | Biocompatibles UK Limited | Drug carriers comprising amphiphilic block copolymers |
| US7807348B2 (en) | 2002-03-20 | 2010-10-05 | Wisconsin Alumni Research Foundation | Optical imaging of nanostructured substrates |
| EP1499895B1 (en) | 2002-04-22 | 2008-05-07 | University Of Florida | Functionalized nanoparticles and methods of use |
| SE0201468D0 (sv) * | 2002-05-13 | 2002-05-13 | Peter Aasberg | Metod att använda luminescenta polymerer för detektion av biospecifik växelverkan |
| US20050058689A1 (en) | 2003-07-03 | 2005-03-17 | Reactive Surfaces, Ltd. | Antifungal paints and coatings |
| US7157409B2 (en) | 2002-09-25 | 2007-01-02 | M-I Llc | Surfactant-polymer compositions for enhancing the stability of viscoelastic-surfactant based fluid |
| DE10261750A1 (de) | 2002-12-30 | 2004-07-15 | Basf Ag | Ampholytisches Copolymer und dessen Verwendung |
| SE0400073D0 (sv) | 2003-04-04 | 2004-01-14 | Appear Sweden Hb | Antibacterial material |
| DE602004031331D1 (de) | 2003-05-15 | 2011-03-24 | Arch Uk Biocides Ltd | Antimikrobielle zusammensetzung enthaltend eine polymerische biguanide und ein copolymer und deren verwendung |
| US7291427B2 (en) * | 2004-03-19 | 2007-11-06 | Fujifilm Corporation | Surface graft material, conductive pattern material, and production method thereof |
| WO2006085898A1 (en) * | 2004-05-14 | 2006-08-17 | Becton, Dickinson & Company | Articles having bioactive surfaces and solvent-free methods of preparation thereof |
| US20060183863A1 (en) | 2005-02-14 | 2006-08-17 | Ciphergen Biosystems, Inc. | Zwitterionic polymers |
| JP4435709B2 (ja) * | 2005-03-22 | 2010-03-24 | 富士フイルム株式会社 | バイオセンサー |
| TWI326691B (en) | 2005-07-22 | 2010-07-01 | Kraton Polymers Res Bv | Sulfonated block copolymers, method for making same, and various uses for such block copolymers |
| US7445879B2 (en) | 2005-08-23 | 2008-11-04 | Nukote International, Inc. | Preparation of suspension polymerized toners |
| CA2619361C (en) * | 2005-08-25 | 2015-10-20 | University Of Washington | Super-low fouling sulfobetaine and carboxybetaine materials and related methods |
| EP1922372A4 (en) | 2005-09-06 | 2010-11-10 | Novus Int Inc | Marine antifouling coating compositions |
| US8124128B2 (en) | 2005-11-08 | 2012-02-28 | Industrial Technology Research Institute | Amphiphilic block copolymers and nano particles comprising the same |
| JP4961133B2 (ja) | 2005-11-10 | 2012-06-27 | 大阪有機化学工業株式会社 | 医療用材料 |
| FR2894585B1 (fr) | 2005-12-14 | 2012-04-27 | Rhodia Recherches Et Tech | Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation |
| DE102006004111B4 (de) | 2006-01-28 | 2015-11-19 | Wöhlk-Contact-Linsen GmbH | Kontaktlinsenmaterial |
| FR2898067B1 (fr) | 2006-03-03 | 2008-05-30 | Rhodia Recherches & Tech | Modification de surfaces solides par des associations de polymeres |
| EP2069412B1 (en) | 2006-08-07 | 2019-01-02 | University of Washington | Mixed charge copolymers and hydrogels |
| MX2009007101A (es) | 2006-12-29 | 2009-12-01 | Univ Washington | Superficies y materiales antibioincrustación bifuncionales. |
| US20080299177A1 (en) | 2007-06-06 | 2008-12-04 | Biovaluation & Analysis, Inc. | Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| EP2225331B1 (en) | 2007-11-19 | 2016-01-06 | University of Washington | Marine coatings |
| WO2009099126A1 (ja) | 2008-02-07 | 2009-08-13 | Riken | 光反応性共重合体、表面改質剤、親水化処理剤、吸着抑制剤、物質固定化剤、表面改質方法、親水化方法、吸着抑制方法および物質固定化方法 |
| CN102906127A (zh) | 2009-11-06 | 2013-01-30 | 华盛顿大学商业中心 | 来自两性离子聚合物的自组装颗粒以及相关的方法 |
| US10031138B2 (en) | 2012-01-20 | 2018-07-24 | University Of Washington Through Its Center For Commercialization | Hierarchical films having ultra low fouling and high recognition element loading properties |
-
2007
- 2007-12-31 MX MX2009007101A patent/MX2009007101A/es not_active Application Discontinuation
- 2007-12-31 EP EP07866139A patent/EP2104846A2/en not_active Withdrawn
- 2007-12-31 CA CA002674632A patent/CA2674632A1/en not_active Abandoned
- 2007-12-31 JP JP2009544325A patent/JP2010530955A/ja active Pending
- 2007-12-31 WO PCT/US2007/089236 patent/WO2008083390A2/en not_active Ceased
-
2009
- 2009-06-29 US US12/493,649 patent/US8835144B2/en active Active
-
2014
- 2014-08-27 US US14/470,775 patent/US9535062B2/en not_active Expired - Fee Related
-
2016
- 2016-12-30 US US15/396,128 patent/US10060918B2/en active Active
-
2018
- 2018-08-27 US US16/113,918 patent/US20190219570A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US9535062B2 (en) | 2017-01-03 |
| JP2010530955A (ja) | 2010-09-16 |
| WO2008083390A2 (en) | 2008-07-10 |
| US8835144B2 (en) | 2014-09-16 |
| US20190219570A1 (en) | 2019-07-18 |
| US10060918B2 (en) | 2018-08-28 |
| US20170108492A1 (en) | 2017-04-20 |
| US20100099160A1 (en) | 2010-04-22 |
| WO2008083390A3 (en) | 2008-12-11 |
| EP2104846A2 (en) | 2009-09-30 |
| US20140370567A1 (en) | 2014-12-18 |
| MX2009007101A (es) | 2009-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10060918B2 (en) | Dual-functional nonfouling surfaces comprising target binding partner covalently coupled to polymer attached to substrate | |
| JP2010530955A5 (https=) | ||
| Khumsap et al. | Epitope-imprinted polymers: applications in protein recognition and separation | |
| Goto et al. | Polymer nanoparticles covered with phosphorylcholine groups and immobilized with antibody for high-affinity separation of proteins | |
| Chou et al. | Ultra-low fouling and high antibody loading zwitterionic hydrogel coatings for sensing and detection in complex media | |
| US10031138B2 (en) | Hierarchical films having ultra low fouling and high recognition element loading properties | |
| Li et al. | Block copolymer modified surfaces for conjugation of biomacromolecules with control of quantity and activity | |
| US8585972B2 (en) | Biosensor | |
| Son et al. | Amine-reactive poly (pentafluorophenyl acrylate) brush platforms for cleaner protein purification | |
| US7563623B2 (en) | Biosensor | |
| Zilio et al. | New “clickable” polymeric coating for glycan microarrays | |
| Wischerhoff et al. | Smart polymer surfaces: Concepts and applications in biosciences | |
| JP5543179B2 (ja) | 標識独立検出バイオセンサ組成およびその方法 | |
| WO2009145359A1 (en) | Graft polymer-containing substrate, method for producing the same, target substance-detecting element, and target substance detection kit | |
| JP5409671B2 (ja) | アフィニティヒドロゲルとその標識非依存性検出方法 | |
| US20060287453A1 (en) | Phosphorus-containing polymers for optical signal transducers | |
| JP4887863B2 (ja) | 光固定化方法及び構造体 | |
| Szweda et al. | Polymer-peptide/protein conjugates on the surface | |
| Cooper | Sensor surfaces and receptor deposition | |
| JP4568175B2 (ja) | バイオセンサー及び生理活性物質の固定化方法 | |
| US20230251257A1 (en) | Substrate for immobilizing substance, and use thereof | |
| JP2011007785A (ja) | 標的分子相互作用物質固定化担体 | |
| 寺田侑平 | Molecular Recognition Analyses of Glycopolymer by Optical Biosensing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20131231 |